Veterinary Medicines

Lenzelta, Suspension for injection

Authorised
  • Escherichia coli, serotype O111, strain J5, Inactivated
  • Staphylococcus aureus, strain DSM 4910, Inactivated
Download as PDF

Product identification

Medicine name:
Lenzelta, Suspension for injection
Lenzelta suspensie voor injectie voor runderen
Active substance:
  • Escherichia coli, serotype O111, strain J5, Inactivated
  • Staphylococcus aureus, strain DSM 4910, Inactivated
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Escherichia coli, serotype O111, strain J5, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Staphylococcus aureus, strain DSM 4910, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB17
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Glass Vial 10 x 5.0 Dose obal- plastová krabička
  • Plastic (HDPE) Vial 10 x 5.0 Dose obal- plastová krabička
  • Glass Vial 1 x 5.0 Dose obal- papírová krabička
  • Plastic (HDPE) Vial 1 x 5.0 Dose obal- papírová krabička
  • Glass Vial 1 x 25.0 Dose obal- papírová krabička
  • Plastic (HDPE) Vial 1 x 25.0 Dose obal- papírová krabička
  • Glass Vial 1 x 50.0 Dose obal- papírová krabička
  • Plastic (HDPE) Vial 1 x 50.0 Dose obal- papírová krabička

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 134465
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0204/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 2/01/2026
Download